Verrica Pharmaceuticals Inc

XNAS:VRCA

3.61

+0.08 (+2.27%)

7:52:24 PM EDT: $3.46 -0.15 (-4.16%)

Market Cap (Intraday)	34.87M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.34 Million
Adjusted EPS	-$0.51

See more estimates

10-Day MA	$3.79
50-Day MA	$4.53
200-Day MA	$5.70

See more pivots

Verrica Pharmaceuticals Inc Stock, XNAS:VRCA

44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380

United States of America

Phone: +1.434.453.3300

Number of Employees: 71

http://www.verrica.com

Description

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.